Skip to main content
Top
Published in: Breast Cancer Research 5/2005

Open Access 01-10-2005 | Research article

Percentage density, Wolfe's and Tabár's mammographic patterns: agreement and association with risk factors for breast cancer

Authors: Inger T Gram, Yngve Bremnes, Giske Ursin, Gertraud Maskarinec, Nils Bjurstam, Eiliv Lund

Published in: Breast Cancer Research | Issue 5/2005

Login to get access

Abstract

Introduction

The purpose of this report was to classify mammograms according to four methods and to examine their agreement and their relationship to selected risk factors for breast cancer.

Method

Mammograms and epidemiological data were collected from 987 women, aged 55 to 71 years, attending the Norwegian Breast Cancer Screening Program. Two readers each classified the mammograms according to a quantitative method (Cumulus or Madena software) and one reader according to two qualitative methods (Wolfe and Tabár patterns). Mammograms classified in the reader-specific upper quartile of percentage density, Wolfe's P2 and DY patterns, or Tabár's IV and V patterns, were categorized as high-risk density patterns and the remaining mammograms as low-risk density patterns. We calculated intra-reader and inter-reader agreement and estimated prevalence odds ratios of having high-risk mammographic density patterns according to selected risk factors for breast cancer.

Results

The Pearson correlation coefficient was 0.86 for the two quantitative density measurements. There was moderate agreement between the Wolfe and Tabár classifications (Kappa = 0.51; 95% confidence interval 0.46 to 0.56). Age at screening, number of children and body mass index (BMI) showed a statistically significant inverse relationship with high-risk density patterns for all four methods (all P < 0.05). After adjustment for percentage density, the Wolfe classification was not associated with any of the risk factors for breast cancer, whereas the association with number of children and BMI remained statistically significant for the Tabár classification. Adjustment for Wolfe or Tabár patterns did not alter the associations between these risk factors and percentage mammographic density.

Conclusion

The four assessments methods seem to capture the same overall associations with risk factors for breast cancer. Our results indicate that the quantitative methods convey additional information over the qualitative methods.
Literature
1.
go back to reference Wolfe JN: Risk for breast cancer development determined by mammographic parenchymal pattern. Cancer. 1976, 37: 2486-2492.CrossRefPubMed Wolfe JN: Risk for breast cancer development determined by mammographic parenchymal pattern. Cancer. 1976, 37: 2486-2492.CrossRefPubMed
2.
go back to reference American College of Radiology: Breast Imaging Reporting and Data System (BI-RADS). 1995, Reston: American College of Radiology, 2 American College of Radiology: Breast Imaging Reporting and Data System (BI-RADS). 1995, Reston: American College of Radiology, 2
3.
go back to reference Gram IT, Funkhouser E, Tabar L: The Tabar classification of mammographic parenchymal patterns. Eur J Radiol. 1997, 24: 131-136. 10.1016/S0720-048X(96)01138-2.CrossRefPubMed Gram IT, Funkhouser E, Tabar L: The Tabar classification of mammographic parenchymal patterns. Eur J Radiol. 1997, 24: 131-136. 10.1016/S0720-048X(96)01138-2.CrossRefPubMed
4.
go back to reference Boyd NF, Byng JW, Jong RA, Fishell EK, Little LE, Miller AB, Lockwood GA, Tritchler DL, Yaffe MJ: Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Inst. 1995, 87: 670-675.CrossRefPubMed Boyd NF, Byng JW, Jong RA, Fishell EK, Little LE, Miller AB, Lockwood GA, Tritchler DL, Yaffe MJ: Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Inst. 1995, 87: 670-675.CrossRefPubMed
5.
go back to reference Ursin G, Astrahan MA, Salane M, Parisky YR, Pearce JG, Daniels JR, Pike MC, Spicer DV: The detection of changes in mammographic densities. Cancer Epidemiol Biomarkers Prev. 1998, 7: 43-47.PubMed Ursin G, Astrahan MA, Salane M, Parisky YR, Pearce JG, Daniels JR, Pike MC, Spicer DV: The detection of changes in mammographic densities. Cancer Epidemiol Biomarkers Prev. 1998, 7: 43-47.PubMed
6.
go back to reference Saftlas AF, Szklo M: Mammographic parenchymal patterns and breast cancer risk. Epidemiol Rev. 1987, 9: 146-174.CrossRefPubMed Saftlas AF, Szklo M: Mammographic parenchymal patterns and breast cancer risk. Epidemiol Rev. 1987, 9: 146-174.CrossRefPubMed
7.
go back to reference Oza AM, Boyd NF: Mammographic parenchymal patterns: a marker of breast cancer risk. Epidemiol Rev. 1993, 15: 196-208. 10.2188/jea.15.S196.CrossRefPubMed Oza AM, Boyd NF: Mammographic parenchymal patterns: a marker of breast cancer risk. Epidemiol Rev. 1993, 15: 196-208. 10.2188/jea.15.S196.CrossRefPubMed
8.
go back to reference Gram IT, Funkhouser E, Tabar L: Reproductive and menstrual factors in relation to mammographic parenchymal patterns among perimenopausal women. Br J Cancer. 1995, 71: 647-650.CrossRefPubMedPubMedCentral Gram IT, Funkhouser E, Tabar L: Reproductive and menstrual factors in relation to mammographic parenchymal patterns among perimenopausal women. Br J Cancer. 1995, 71: 647-650.CrossRefPubMedPubMedCentral
9.
go back to reference Jakes RW, Duffy SW, Ng FC, Gao F, Ng EH, Seow A, Lee HP, Yu MC: Mammographic Parenchymal Patterns and Self-reported Soy Intake in Singapore Chinese Women. Cancer Epidemiol Biomarkers Prev. 2002, 11: 608-613.PubMed Jakes RW, Duffy SW, Ng FC, Gao F, Ng EH, Seow A, Lee HP, Yu MC: Mammographic Parenchymal Patterns and Self-reported Soy Intake in Singapore Chinese Women. Cancer Epidemiol Biomarkers Prev. 2002, 11: 608-613.PubMed
10.
go back to reference Greendale GA, Reboussin BA, Sie A, Singh HR, Olson LK, Gatewood O, Bassett LW, Wasilauskas C, Bush T, Barrett-Connor E: Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal Estrogen/Progestin Interventions (PEPI) Investigators. Ann Intern Med. 1999, 130: 262-269.CrossRefPubMed Greendale GA, Reboussin BA, Sie A, Singh HR, Olson LK, Gatewood O, Bassett LW, Wasilauskas C, Bush T, Barrett-Connor E: Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal Estrogen/Progestin Interventions (PEPI) Investigators. Ann Intern Med. 1999, 130: 262-269.CrossRefPubMed
11.
go back to reference Freedman M, San Martin J, O'Gorman J, Eckert S, Lippman ME, Lo SC, Walls EL, Zeng J: Digitized mammography: a clinical trial of postmenopausal women randomly assigned to receive raloxifene, estrogen, or placebo. J Natl Cancer Inst. 2001, 93: 51-56. 10.1093/jnci/93.1.51.CrossRefPubMed Freedman M, San Martin J, O'Gorman J, Eckert S, Lippman ME, Lo SC, Walls EL, Zeng J: Digitized mammography: a clinical trial of postmenopausal women randomly assigned to receive raloxifene, estrogen, or placebo. J Natl Cancer Inst. 2001, 93: 51-56. 10.1093/jnci/93.1.51.CrossRefPubMed
12.
go back to reference Greendale GA, Reboussin BA, Slone S, Wasilauskas C, Pike MC, Ursin G: Postmenopausal hormone therapy and change in mammographic density. J Natl Cancer Inst. 2003, 95: 30-37.CrossRefPubMed Greendale GA, Reboussin BA, Slone S, Wasilauskas C, Pike MC, Ursin G: Postmenopausal hormone therapy and change in mammographic density. J Natl Cancer Inst. 2003, 95: 30-37.CrossRefPubMed
13.
go back to reference Chow CK, Venzon D, Jones EC, Premkumar A, O'Shaughnessy J, Zujewski J: Effect of tamoxifen on mammographic density. Cancer Epidemiol Biomarkers Prev. 2000, 9: 917-921.PubMed Chow CK, Venzon D, Jones EC, Premkumar A, O'Shaughnessy J, Zujewski J: Effect of tamoxifen on mammographic density. Cancer Epidemiol Biomarkers Prev. 2000, 9: 917-921.PubMed
14.
go back to reference Spicer DV, Ursin G, Parisky YR, Pearce JG, Shoupe D, Pike A, Pike MC: Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk. J Natl Cancer Inst. 1994, 86: 431-436.CrossRefPubMed Spicer DV, Ursin G, Parisky YR, Pearce JG, Shoupe D, Pike A, Pike MC: Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk. J Natl Cancer Inst. 1994, 86: 431-436.CrossRefPubMed
15.
go back to reference Boyd NF, Lockwood GA, Martin LJ, Byng JW, Yaffe MJ, Tritchler DL: Mammographic density as a marker of susceptibility to breast cancer: a hypothesis. IARC Sci Publ. 2001, 154: 163-169.PubMed Boyd NF, Lockwood GA, Martin LJ, Byng JW, Yaffe MJ, Tritchler DL: Mammographic density as a marker of susceptibility to breast cancer: a hypothesis. IARC Sci Publ. 2001, 154: 163-169.PubMed
16.
go back to reference Maskarinec G, Williams AE, Carlin L: Mammographic densities in a one-year isoflavone intervention. Eur J Cancer Prev. 2003, 12: 165-169. 10.1097/00008469-200304000-00011.CrossRefPubMed Maskarinec G, Williams AE, Carlin L: Mammographic densities in a one-year isoflavone intervention. Eur J Cancer Prev. 2003, 12: 165-169. 10.1097/00008469-200304000-00011.CrossRefPubMed
17.
go back to reference Atkinson C, Warren RM, Sala E, Dowsett M, Dunning AM, Healey CS, Runswick S, Day NE, Bingham SA: Red-clover-derived isoflavones and mammographic breast density: a double-blind, randomized, placebo-controlled trial [ISRCTN42940165]. Breast Cancer Res. 2004, 6: R170-R179. 10.1186/bcr773.CrossRefPubMedPubMedCentral Atkinson C, Warren RM, Sala E, Dowsett M, Dunning AM, Healey CS, Runswick S, Day NE, Bingham SA: Red-clover-derived isoflavones and mammographic breast density: a double-blind, randomized, placebo-controlled trial [ISRCTN42940165]. Breast Cancer Res. 2004, 6: R170-R179. 10.1186/bcr773.CrossRefPubMedPubMedCentral
18.
go back to reference Cuzick J, Warwick J, Pinney E, Warren RM, Duffy SW: Tamoxifen and breast density in women at increased risk of breast cancer. J Natl Cancer Inst. 2004, 96: 621-628.CrossRefPubMed Cuzick J, Warwick J, Pinney E, Warren RM, Duffy SW: Tamoxifen and breast density in women at increased risk of breast cancer. J Natl Cancer Inst. 2004, 96: 621-628.CrossRefPubMed
19.
go back to reference Couto E, Harrison D, Duffy S, Myles J, Sala E, Warren R, Day N, Luben R, Chen H: Estimation of disease progression parameters from case-control data: application to mammographic patterns and breast cancer natural history. J Epidemiol Biostat. 2001, 6: 235-242. 10.1080/135952201753173015.CrossRefPubMed Couto E, Harrison D, Duffy S, Myles J, Sala E, Warren R, Day N, Luben R, Chen H: Estimation of disease progression parameters from case-control data: application to mammographic patterns and breast cancer natural history. J Epidemiol Biostat. 2001, 6: 235-242. 10.1080/135952201753173015.CrossRefPubMed
20.
go back to reference Ciatto S, Visioli C, Paci E, Zappa M: Breast density as a determinant of interval cancer at mammographic screening. Br J Cancer. 2004, 90: 393-396. 10.1038/sj.bjc.6601548.CrossRefPubMedPubMedCentral Ciatto S, Visioli C, Paci E, Zappa M: Breast density as a determinant of interval cancer at mammographic screening. Br J Cancer. 2004, 90: 393-396. 10.1038/sj.bjc.6601548.CrossRefPubMedPubMedCentral
21.
go back to reference Sala E, Warren R, McCann J, Duffy S, Day N, Luben R: Mammographic parenchymal patterns and mode of detection: implications for the breast screening programme. J Med Screen. 1998, 5: 207-212.CrossRefPubMed Sala E, Warren R, McCann J, Duffy S, Day N, Luben R: Mammographic parenchymal patterns and mode of detection: implications for the breast screening programme. J Med Screen. 1998, 5: 207-212.CrossRefPubMed
22.
go back to reference Warren RM, Young JR, McLean L, Lyons K, Wilson AR, Evans A, Duffy SW, Warsi IM: Radiology review of the UKCCCR Breast Screening Frequency Trial: potential improvements in sensitivity and lead time of radiological signs. Clin Radiol. 2003, 58: 128-132. 10.1053/crad.2002.1132.CrossRefPubMed Warren RM, Young JR, McLean L, Lyons K, Wilson AR, Evans A, Duffy SW, Warsi IM: Radiology review of the UKCCCR Breast Screening Frequency Trial: potential improvements in sensitivity and lead time of radiological signs. Clin Radiol. 2003, 58: 128-132. 10.1053/crad.2002.1132.CrossRefPubMed
23.
go back to reference Harrison DA, Duffy SW, Sala E, Warren RM, Couto E, Day NE: Deterministic models for breast cancer progression: application to the association between mammographic parenchymal pattern and histologic grade of breast cancers. J Clin Epidemiol. 2002, 55: 1113-1118. 10.1016/S0895-4356(02)00483-3.CrossRefPubMed Harrison DA, Duffy SW, Sala E, Warren RM, Couto E, Day NE: Deterministic models for breast cancer progression: application to the association between mammographic parenchymal pattern and histologic grade of breast cancers. J Clin Epidemiol. 2002, 55: 1113-1118. 10.1016/S0895-4356(02)00483-3.CrossRefPubMed
24.
go back to reference Wolfe JN, Saftlas AF, Salane M: Mammographic parenchymal patterns and quantitative evaluation of mammographic densities: a case-control study. AJR Am J Roentgenol. 1987, 148: 1087-1092.CrossRefPubMed Wolfe JN, Saftlas AF, Salane M: Mammographic parenchymal patterns and quantitative evaluation of mammographic densities: a case-control study. AJR Am J Roentgenol. 1987, 148: 1087-1092.CrossRefPubMed
25.
go back to reference Warner E, Lockwood G, Tritchler D, Boyd NF: The risk of breast cancer associated with mammographic parenchymal patterns: a meta-analysis of the published literature to examine the effect of method of classification. Cancer Detect Prev. 1992, 16: 67-72.PubMed Warner E, Lockwood G, Tritchler D, Boyd NF: The risk of breast cancer associated with mammographic parenchymal patterns: a meta-analysis of the published literature to examine the effect of method of classification. Cancer Detect Prev. 1992, 16: 67-72.PubMed
26.
go back to reference Boyd NF, Lockwood GA, Byng JW, Tritchler DL, Yaffe MJ: Mammographic densities and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 1998, 7: 1133-1144.PubMed Boyd NF, Lockwood GA, Byng JW, Tritchler DL, Yaffe MJ: Mammographic densities and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 1998, 7: 1133-1144.PubMed
27.
go back to reference Ursin G, Ma H, Wu AH, Bernstein L, Salane M, Parisky YR, Astrahan M, Siozon CC, Pike MC: Mammographic density and breast cancer in three ethnic groups. Cancer Epidemiol Biomarkers Prev. 2003, 12: 332-338.PubMed Ursin G, Ma H, Wu AH, Bernstein L, Salane M, Parisky YR, Astrahan M, Siozon CC, Pike MC: Mammographic density and breast cancer in three ethnic groups. Cancer Epidemiol Biomarkers Prev. 2003, 12: 332-338.PubMed
28.
go back to reference Maskarinec G, Meng L: A case-control study of mammographic densities in Hawaii. Breast Cancer Res Treat. 2000, 63: 153-161. 10.1023/A:1006486319848.CrossRefPubMed Maskarinec G, Meng L: A case-control study of mammographic densities in Hawaii. Breast Cancer Res Treat. 2000, 63: 153-161. 10.1023/A:1006486319848.CrossRefPubMed
29.
go back to reference Vacek PM, Geller BM: A prospective study of breast cancer risk using routine mammographic breast density measurements. Cancer Epidemiol Biomarkers Prev. 2004, 13: 715-722.PubMed Vacek PM, Geller BM: A prospective study of breast cancer risk using routine mammographic breast density measurements. Cancer Epidemiol Biomarkers Prev. 2004, 13: 715-722.PubMed
30.
go back to reference Jakes RW, Duffy SW, Ng FC, Gao F, Ng EH: Mammographic parenchymal patterns and risk of breast cancer at and after a prevalence screen in Singaporean women. Int J Epidemiol. 2000, 29: 11-19. 10.1093/ije/29.1.11.CrossRefPubMed Jakes RW, Duffy SW, Ng FC, Gao F, Ng EH: Mammographic parenchymal patterns and risk of breast cancer at and after a prevalence screen in Singaporean women. Int J Epidemiol. 2000, 29: 11-19. 10.1093/ije/29.1.11.CrossRefPubMed
31.
go back to reference Byrne C, Hankinson SE, Pollak M, Willett WC, Colditz GA, Speizer FE: Insulin-like growth factors and mammographic density. Growth Horm IGF Res. 2000, 10 (Suppl A): S24-S25. 10.1016/S1096-6374(00)90011-X.CrossRefPubMed Byrne C, Hankinson SE, Pollak M, Willett WC, Colditz GA, Speizer FE: Insulin-like growth factors and mammographic density. Growth Horm IGF Res. 2000, 10 (Suppl A): S24-S25. 10.1016/S1096-6374(00)90011-X.CrossRefPubMed
32.
go back to reference Haiman CA, Hankinson SE, De V, Guillemette C, Ishibe N, Hunter DJ, Byrne C: Polymorphisms in steroid hormone pathway genes and mammographic density. Breast Cancer Res Treat. 2003, 77: 27-36. 10.1023/A:1021112121782.CrossRefPubMed Haiman CA, Hankinson SE, De V, Guillemette C, Ishibe N, Hunter DJ, Byrne C: Polymorphisms in steroid hormone pathway genes and mammographic density. Breast Cancer Res Treat. 2003, 77: 27-36. 10.1023/A:1021112121782.CrossRefPubMed
33.
go back to reference van Gils CH, Hendriks JH, Otten JD, Holland R, Verbeek AL: Parity and mammographic breast density in relation to breast cancer risk: indication of interaction. Eur J Cancer Prev. 2000, 9: 105-111. 10.1097/00008469-200004000-00006.CrossRefPubMed van Gils CH, Hendriks JH, Otten JD, Holland R, Verbeek AL: Parity and mammographic breast density in relation to breast cancer risk: indication of interaction. Eur J Cancer Prev. 2000, 9: 105-111. 10.1097/00008469-200004000-00006.CrossRefPubMed
34.
go back to reference Byng JW, Yaffe MJ, Lockwood GA, Little LE, Tritchler DL, Boyd NF: Automated analysis of mammographic densities and breast carcinoma risk. Cancer. 1997, 80: 66-74. 10.1002/(SICI)1097-0142(19970701)80:1<66::AID-CNCR9>3.0.CO;2-D.CrossRefPubMed Byng JW, Yaffe MJ, Lockwood GA, Little LE, Tritchler DL, Boyd NF: Automated analysis of mammographic densities and breast carcinoma risk. Cancer. 1997, 80: 66-74. 10.1002/(SICI)1097-0142(19970701)80:1<66::AID-CNCR9>3.0.CO;2-D.CrossRefPubMed
35.
go back to reference Maskarinec G, Meng L, Ursin G: Ethnic differences in mammographic densities. Int J Epidemiol. 2001, 30: 959-965. 10.1093/ije/30.5.959.CrossRefPubMed Maskarinec G, Meng L, Ursin G: Ethnic differences in mammographic densities. Int J Epidemiol. 2001, 30: 959-965. 10.1093/ije/30.5.959.CrossRefPubMed
36.
go back to reference Maskarinec G, Lyu LC, Meng L, Theriault A, Ursin G: Determinants of mammographic densities among women of Asian, Native Hawaiian, and Caucasian ancestry. Ethn Dis. 2001, 11: 44-50.PubMed Maskarinec G, Lyu LC, Meng L, Theriault A, Ursin G: Determinants of mammographic densities among women of Asian, Native Hawaiian, and Caucasian ancestry. Ethn Dis. 2001, 11: 44-50.PubMed
37.
go back to reference Bjurstam N, Bjorneld L, Warwick J, Sala E, Duffy SW, Nystrom L, Walker N, Cahlin E, Eriksson O, Hafstrom LO, et al: The Gothenburg Breast Screening Trial. Cancer. 2003, 97: 2387-2396. 10.1002/cncr.11361.CrossRefPubMed Bjurstam N, Bjorneld L, Warwick J, Sala E, Duffy SW, Nystrom L, Walker N, Cahlin E, Eriksson O, Hafstrom LO, et al: The Gothenburg Breast Screening Trial. Cancer. 2003, 97: 2387-2396. 10.1002/cncr.11361.CrossRefPubMed
38.
39.
go back to reference Fleiss JL: Statistical methods for rates and Proportions. 1981, New York: Wiley, 2 Fleiss JL: Statistical methods for rates and Proportions. 1981, New York: Wiley, 2
40.
go back to reference SAS/STAT User's Guide. 1999, Cary, NC: SAS Institute Inc SAS/STAT User's Guide. 1999, Cary, NC: SAS Institute Inc
41.
go back to reference Venta LA, Hendrick RE, Adler YT, DeLeon P, Mengoni PM, Scharl AM, Comstock CE, Hansen L, Kay N, Coveler A, et al: Rates and causes of disagreement in interpretation of full-field digital mammography and film-screen mammography in a diagnostic setting. AJR Am J Roentgenol. 2001, 176: 1241-1248.CrossRefPubMed Venta LA, Hendrick RE, Adler YT, DeLeon P, Mengoni PM, Scharl AM, Comstock CE, Hansen L, Kay N, Coveler A, et al: Rates and causes of disagreement in interpretation of full-field digital mammography and film-screen mammography in a diagnostic setting. AJR Am J Roentgenol. 2001, 176: 1241-1248.CrossRefPubMed
42.
go back to reference Brisson J, Diorio C, Masse B: Wolfe's parenchymal pattern and percentage of the breast with mammographic densities: redundant or complementary classifications?. Cancer Epidemiol Biomarkers Prev. 2003, 12: 728-732.PubMed Brisson J, Diorio C, Masse B: Wolfe's parenchymal pattern and percentage of the breast with mammographic densities: redundant or complementary classifications?. Cancer Epidemiol Biomarkers Prev. 2003, 12: 728-732.PubMed
43.
go back to reference Funkhouser E, Waterbor JW, Cole P, Rubin E: Mammographic patterns and breast cancer risk factors among women having elective screening. South Med J. 1993, 86: 177-180.CrossRefPubMed Funkhouser E, Waterbor JW, Cole P, Rubin E: Mammographic patterns and breast cancer risk factors among women having elective screening. South Med J. 1993, 86: 177-180.CrossRefPubMed
44.
go back to reference Vachon CM, Kuni CC, Anderson K, Anderson VE, Sellers TA: Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States). Cancer Causes Control. 2000, 11: 653-662. 10.1023/A:1008926607428.CrossRefPubMed Vachon CM, Kuni CC, Anderson K, Anderson VE, Sellers TA: Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States). Cancer Causes Control. 2000, 11: 653-662. 10.1023/A:1008926607428.CrossRefPubMed
45.
go back to reference El Bastawissi AY, White E, Mandelson MT, Taplin SH: Reproductive and hormonal factors associated with mammographic breast density by age (United States). Cancer Causes Control. 2000, 11: 955-963. 10.1023/A:1026514032085.CrossRefPubMed El Bastawissi AY, White E, Mandelson MT, Taplin SH: Reproductive and hormonal factors associated with mammographic breast density by age (United States). Cancer Causes Control. 2000, 11: 955-963. 10.1023/A:1026514032085.CrossRefPubMed
46.
go back to reference Andersson I, Janzon L, Pettersson H: Radiographic patterns of the mammary parenchyma: variation with age at examination and age at first birth. Radiology. 1981, 138: 59-62.CrossRefPubMed Andersson I, Janzon L, Pettersson H: Radiographic patterns of the mammary parenchyma: variation with age at examination and age at first birth. Radiology. 1981, 138: 59-62.CrossRefPubMed
47.
go back to reference Sala E, Warren R, McCann J, Duffy S, Luben R, Day N: High-risk mammographic parenchymal patterns, hormone replacement therapy and other risk factors: a case-control study. Int J Epidemiol. 2000, 29: 629-636. 10.1093/ije/29.4.629.CrossRefPubMed Sala E, Warren R, McCann J, Duffy S, Luben R, Day N: High-risk mammographic parenchymal patterns, hormone replacement therapy and other risk factors: a case-control study. Int J Epidemiol. 2000, 29: 629-636. 10.1093/ije/29.4.629.CrossRefPubMed
48.
go back to reference Myles JP, Salmininen T, Duffy SW, Prevost TC, Day NE, Hakama M: Prospective estimation of rates of change in mammographic parenchymal patterns: influence of age and of hormone replacement therapy. Breast. 2004, 13: 56-60. 10.1016/j.breast.2003.10.007.CrossRefPubMed Myles JP, Salmininen T, Duffy SW, Prevost TC, Day NE, Hakama M: Prospective estimation of rates of change in mammographic parenchymal patterns: influence of age and of hormone replacement therapy. Breast. 2004, 13: 56-60. 10.1016/j.breast.2003.10.007.CrossRefPubMed
49.
go back to reference Warren R: Hormones and mammographic breast density. Maturitas. 2004, 49: 67-78. 10.1016/j.maturitas.2004.06.013.CrossRefPubMed Warren R: Hormones and mammographic breast density. Maturitas. 2004, 49: 67-78. 10.1016/j.maturitas.2004.06.013.CrossRefPubMed
50.
go back to reference Ursin G, Pike MC, Spicer DV, Porrath SA, Reitherman RW: Can mammographic densities predict effects of tamoxifen on the breast?. J Natl Cancer Inst. 1996, 88: 128-129.CrossRefPubMed Ursin G, Pike MC, Spicer DV, Porrath SA, Reitherman RW: Can mammographic densities predict effects of tamoxifen on the breast?. J Natl Cancer Inst. 1996, 88: 128-129.CrossRefPubMed
51.
go back to reference Gram IT, Ursin G, Spicer DV, Pike MC: Reversal of gonadotropin-releasing hormone agonist induced reductions in mammographic densities on stopping treatment. Cancer Epidemiol Biomarkers Prev. 2001, 10: 1117-1120.PubMed Gram IT, Ursin G, Spicer DV, Pike MC: Reversal of gonadotropin-releasing hormone agonist induced reductions in mammographic densities on stopping treatment. Cancer Epidemiol Biomarkers Prev. 2001, 10: 1117-1120.PubMed
52.
go back to reference Rutter CM, Mandelson MT, Laya MB, Seger DJ, Taplin S: Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy. JAMA. 2001, 285: 171-176. 10.1001/jama.285.2.171.CrossRefPubMed Rutter CM, Mandelson MT, Laya MB, Seger DJ, Taplin S: Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy. JAMA. 2001, 285: 171-176. 10.1001/jama.285.2.171.CrossRefPubMed
Metadata
Title
Percentage density, Wolfe's and Tabár's mammographic patterns: agreement and association with risk factors for breast cancer
Authors
Inger T Gram
Yngve Bremnes
Giske Ursin
Gertraud Maskarinec
Nils Bjurstam
Eiliv Lund
Publication date
01-10-2005
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue 5/2005
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr1308

Other articles of this Issue 5/2005

Breast Cancer Research 5/2005 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine